Literature DB >> 7709057

Pituitary-adrenal activity and opioid release in ponies during thiopentone/halothane anaesthesia.

S P Luna1, P M Taylor.   

Abstract

The effect of thiopentone/halothane anaesthesia on the release of endogenous opioid, adrenocorticotrophin, arginine vasopressin, cortisol and catecholamine was investigated in ponies. The contribution made by halothane itself was studied by maintaining six ponies with a constant 1.2 per cent end tidal halothane concentration and five with a concentration ranging between 0.8 and 1.2 per cent. Cardiorespiratory depression was more prolonged in the ponies receiving a constant 1.2 per cent end tidal halothane concentration than in those which received less halothane. Plasma lactate concentration increased and haematocrit decreased during halothane anaesthesia. The concentrations of met-enkephalin, dynorphin and catecholamines did not change and those of beta-endorphin, adrenocorticotrophin, arginine vasopressin and cortisol increased during halothane anaesthesia. Halothane appeared to be a major stimulus to pituitary adrenocortical activation because the adrenocortical secretion was proportional to the amount of halothane inhaled. Beta-endorphin increased proportionally more than adrenocorticotrophin and their plasma concentrations were not correlated, suggesting that they have independent secretion mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7709057     DOI: 10.1016/0034-5288(95)90085-3

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses.

Authors:  D I Rendle; M Duz; J Beech; T Parkin; A E Durham
Journal:  J Vet Intern Med       Date:  2014-10-13       Impact factor: 3.333

2.  Cardiorespiratory and antinociceptive effects of two different doses of lidocaine administered to horses during a constant intravenous infusion of xylazine and ketamine.

Authors:  Pedro I Nóbrega Neto; Stelio P L Luna; Patricia Queiroz-Williams; Khursheed R Mama; Eugene P Steffey; Adriano B Carregaro
Journal:  BMC Vet Res       Date:  2013-10-09       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.